Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLPP | Q16740 | 19/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.84 |
| ▸ | GNRHR | P30968 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30130148 | 1.00 | CLPP (1.00) | CLPPCYP3A4GNRHR | |
| SCHEMBL24914836 | 0.95 | CLPP (1.00) | CLPPCYP3A4GNRHR | |
| SCHEMBL30130267 | 0.95 | CLPP (1.00) | CLPPCYP3A4GNRHR | |
| SCHEMBL30130154 | 0.94 | CLPP (0.88) | CLPPCYP3A4GNRHR | |
| SCHEMBL24914818 | 0.94 | CLPP (1.00) | CLPPCYP3A4GNRHR | |
| SCHEMBL28984476 | 0.94 | CLPP (0.88) | CLPPCYP3A4GNRHR | |
| SCHEMBL28984510 | 0.94 | CLPP (0.88) | CLPPCYP3A4GNRHR | |
| SCHEMBL30130205 | 0.94 | CLPP (1.00) | CLPPCYP3A4GNRHR | |
| SCHEMBL30130012 | 0.94 | CLPP (0.88) | CLPPCYP3A4GNRHR | |
| SCHEMBL24915164 | 0.92 | CLPP (1.00) | CLPPCYP3A4GNRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023284807-A1 | COMPOUND CONTAINING TETRAHYDRONAPHTHYRIDONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF | 中国药科大学 | 2023-01-19 | — | — | WO | disclosed |
| CN-115611896-A | Compound containing tetralone or tetrahydropyridopyrimidone skeleton and preparation method and pharmaceutical application thereof | 中国药科大学 | 2023-01-17 | — | — | CN | disclosed |